Priority-setting for obesity prevention-The Assessing Cost-Effectiveness of obesity prevention policies in Australia (ACE-Obesity Policy) study
- PMID: 32559212
- PMCID: PMC7304600
- DOI: 10.1371/journal.pone.0234804
Priority-setting for obesity prevention-The Assessing Cost-Effectiveness of obesity prevention policies in Australia (ACE-Obesity Policy) study
Abstract
The aim of the ACE-Obesity Policy study was to assess the economic credentials of a suite of obesity prevention policies across multiple sectors and areas of governance for the Australian setting. The study aimed to place the cost-effectiveness results within a broad decision-making context by providing an assessment of the key considerations for policy implementation. The Assessing Cost-Effectiveness (ACE) approach to priority-setting was used. Systematic literature reviews were undertaken to assess the evidence of intervention effectiveness on body mass index and/or physical activity for selected interventions. A standardised evaluation framework was used to assess the cost-effectiveness of each intervention compared to a 'no intervention' comparator, from a limited societal perspective. A multi-state life table Markov cohort model was used to estimate the long-term health impacts (quantified as health adjusted life years (HALYs)) and health care cost-savings resulting from each intervention. In addition to the technical cost-effectiveness results, qualitative assessments of implementation considerations were undertaken. All 16 interventions evaluated were found to be cost-effective (using a willingness-to-pay threshold of AUD50,000 per HALY gained). Eleven interventions were dominant (health promoting and cost-saving). The incremental cost-effectiveness ratio for the non-dominant interventions ranged from AUD1,728 to 28,703 per HALY gained. Regulatory interventions tended to rank higher on their cost-effectiveness results, driven by lower implementation costs. However, the program-based policy interventions were generally based on higher quality evidence of intervention effectiveness. This comparative analysis of the economic credentials of obesity prevention policies for Australia indicates that there are a broad range of policies that are likely to be cost-effective, although policy options vary in strength of evidence for effectiveness, affordability, feasibility, acceptability to stakeholders, equity impact and sustainability. Implementation of these policies will require sustained co-ordination across jurisdictions and multiple government sectors in order to generate the predicted health benefits for the Australian population.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Assessing cost-effectiveness in obesity (ACE-obesity): an overview of the ACE approach, economic methods and cost results.BMC Public Health. 2009 Nov 18;9:419. doi: 10.1186/1471-2458-9-419. BMC Public Health. 2009. PMID: 19922625 Free PMC article.
-
Obesity-related health impacts of fuel excise taxation- an evidence review and cost-effectiveness study.BMC Public Health. 2017 May 4;17(1):359. doi: 10.1186/s12889-017-4271-2. BMC Public Health. 2017. PMID: 28468618 Free PMC article.
-
Cost-effectiveness of community-based childhood obesity prevention interventions in Australia.Int J Obes (Lond). 2019 May;43(5):1102-1112. doi: 10.1038/s41366-019-0341-0. Epub 2019 Mar 29. Int J Obes (Lond). 2019. PMID: 30926947
-
Cost-Effectiveness and Affordability of Interventions, Policies, and Platforms for the Prevention and Treatment of Mental, Neurological, and Substance Use Disorders.In: Patel V, Chisholm D, Dua T, Laxminarayan R, Medina-Mora ME, editors. Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14. Chapter 12. In: Patel V, Chisholm D, Dua T, Laxminarayan R, Medina-Mora ME, editors. Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14. Chapter 12. PMID: 27227237 Free Books & Documents. Review.
-
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280. Health Technol Assess. 2006. PMID: 16904047 Review.
Cited by
-
Comparing dietary strategies to manage cardiovascular risk in primary care: a narrative review of systematic reviews.Br J Gen Pract. 2024 Feb 19;74(740):e199-207. doi: 10.3399/BJGP.2022.0564. Online ahead of print. Br J Gen Pract. 2024. PMID: 38373850 Free PMC article.
-
Cost-effectiveness of reducing children's sedentary time and increasing physical activity at school: the Transform-Us! intervention.Int J Behav Nutr Phys Act. 2024 Feb 12;21(1):15. doi: 10.1186/s12966-024-01560-3. Int J Behav Nutr Phys Act. 2024. PMID: 38347579 Free PMC article. Clinical Trial.
-
Physical Activity and Depression and Anxiety Disorders in Australia: A Lifetable Analysis.AJPM Focus. 2022 Sep 12;2(2):100030. doi: 10.1016/j.focus.2022.100030. eCollection 2023 Jun. AJPM Focus. 2022. PMID: 37790639 Free PMC article.
-
A comparative analysis of the cost-utility of the Philippine tax on sweetened beverages as proposed and as implemented.Lancet Reg Health West Pac. 2023 Sep 27;41:100912. doi: 10.1016/j.lanwpc.2023.100912. eCollection 2023 Dec. Lancet Reg Health West Pac. 2023. PMID: 37780636 Free PMC article.
-
The health and economic impact and cost effectiveness of interventions for the prevention and control of overweight and obesity in Kenya: a stakeholder engaged modelling study.Cost Eff Resour Alloc. 2023 Sep 21;21(1):69. doi: 10.1186/s12962-023-00467-3. Cost Eff Resour Alloc. 2023. PMID: 37735408 Free PMC article.
References
-
- Abarca-Gómez L, Abdeen ZA, Hamid ZA, Abu-Rmeileh NM, Acosta-Cazares B, Acuin C, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. The Lancet. 2017;390(10113):2627–42. 10.1016/S0140-6736(17)32129-3 - DOI - PMC - PubMed
-
- World Health Organization. Obesity and overweight key facts Geneva, Switzerland 2018 [cited 2018 12 November]. http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
-
- Organisation for Economic Co-operation and Development. Obesity Update. Paris, France: 2017.
-
- Australian Institute of Health and Welfare. A picture of overweight and obesity in Australia 2017. Cat. no.PHE 216. Canberra: AIHW, 2017.
-
- GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1659–724. Epub 2016/10/14. 10.1016/S0140-6736(16)31679-8 . - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
